Immunogenicity and Safety Exploration of a Booster Dose of a Live Attenuated Japanese Encephalitis Chimeric Virus Vaccine (IMOJEV) Given One Year After Primary Immunization in Healthy Children in South Korea [EXTENSION OF 700202906]
Latest Information Update: 15 Dec 2017
At a glance
- Drugs Japanese encephalitis vaccine (Primary)
- Indications Japanese encephalitis
- Focus Pharmacodynamics
- Sponsors Sanofi Pasteur
- 03 Nov 2015 Results published in the Pediatric Infectious Disease Journal
- 14 Jan 2014 Status changed from recruiting to active, no longer recruiting, according to ClinicalTrials.gov record.
- 25 Jul 2013 New trial record